MedTrace Logo

Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study

NCT00936312 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2012-12-10

No results posted yet for this study

Summary

This is a multi-center, international study designed to collect clinical, genetic and quality of life information on females with hemophilia, an inherited bleeding disorder. The study is designed to determine whether there are problems and issues unique to females with hemophilia.

Conditions

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • University Hospital, Bonn

    collaborator OTHER

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • William B Mitchell, MD · Weill Medical College of Cornell University

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United States
  • Australia
  • Germany
  • Israel
  • Italy
  • Japan
  • Netherlands
  • Sweden
  • Taiwan

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00936312 on ClinicalTrials.gov